3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)-phenylamino]-methyl}-1-methyl1H-benzimidazol-5-carbonyl)-pyridine-2 -yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament

Details for Australian Patent Application No. 2004274139 (hide)

International Classifications

Event Publications

6 April 2006 PCT application entered the National Phase

PCT publication WO2005/028468 Priority application(s): WO2005/028468

13 May 2010 Application Accepted

Published as AU-B-2004274139

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.